Step 1: Understanding the Concept:
Therapeutic management of canine and feline maternal dystocia due to primary hypocalcemic/hypocontractile uterine inertia.
Step 2: Detailed Explanation:
Medical management of Primary Uterine Inertia (failure of the pregnant myometrium to initiate or sustain normal labor contractions):
- Requires verification of normal birth canal patency (no obstructive fetal dystocia).
- Standard medical protocol combines:
1. $10\%$ Calcium Borogluconate Calcium Gluconate (slowly i/v or s/c): Increases intracellular sarcoplasmic $\text{Ca}^{2+}$ reserves to strengthen the contractile machinery of myometrial smooth muscle.
2. Oxytocin (low-dose protocol, $0.5 - 2\text{ IU}$ i/m): Binds myometrial oxytocin receptors to stimulate rhythmic, coordinated uterine contractions.
- Administering calcium first sensitizes myometrial receptors to oxytocin, optimizing efficacy.
Step 3: Final Answer:
Therefore, primary uterine inertia is treated with a Combination of oxytocin and calcium, matching option (D).